Search

Search Results
Results 4411 - 4420 of 4467 for multiple sclerosis
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Orencia intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Xigduo XR intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Kombiglyze XR intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Metformin Mylan (formerly Diaformin) intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about C-Flox (ciprofloxacin) intended for persons living in Australia.
  • White Paper - 29 May 2023
    In this article, Sino Biological discusses the evolution of antibody humanization and affinity maturation and how this affects the life sciences field.
  • White Paper - 2 Mar 2023
    As one of the main tracks at this year’s Pittcon, researchers will outline several studies that have analyzed and characterized cannabis and psychoactive substances.
  • Drug - 6 Jan 2023
    Consumer Medicine Information (CMI) about Perisyl Combi (perindopril erbumine and indapamide hemihydrate) intended for persons living in Australia.
  • Drug - 6 Jan 2023
    Consumer Medicine Information (CMI) about Perisyl (perindopril erbumine) intended for persons living in Australia.
  • Drug - 16 Dec 2022
    Consumer Medicine Information (CMI) about Juluca intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.